CX3CR1 deficiency accelerates the development of retinopathy in a rodent model of type 1 diabetes
Authors:
- 25 June 2016
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 94 (11) , 1255-1265
Abstract
In this study, the role of CX3CR1 in the progression of diabetic retinopathy (DR) was investigated. The retinas of wild-type (WT), CX3CR1 null (CX3CR1gfp/gKeywords
Funding Information
- National Institutes of Health (DK090730, HL110170)
This publication has 46 references indexed in Scilit:
- Nonclassical Patrolling Monocyte Function in the VasculatureArteriosclerosis, Thrombosis, and Vascular Biology, 2015
- CX3CL1 (Fractalkine) Protein Expression in Normal and Degenerating Mouse Retina: In Vivo StudiesPLOS ONE, 2014
- Neuroinflammation and M2 microglia: the good, the bad, and the inflamedJournal of Neuroinflammation, 2014
- An unbalanced monocyte polarisation in peripheral blood and bone marrow of patients with type 2 diabetes has an impact on microangiopathyDiabetologia, 2013
- The Effects of Age and Cx3cr1 Deficiency on Retinal Microglia in theIns2AkitaDiabetic MouseInvestigative Ophthalmology & Visual Science, 2013
- Effects of Ischemic Preconditioning and Bevacizumab on Apoptosis and Vascular Permeability Following Retinal Ischemia–Reperfusion InjuryInvestigative Ophthalmology & Visual Science, 2010
- The Fractalkine Receptor CX3CR1 Protects Against Liver Fibrosis by Controlling Differentiation and Survival of Infiltrating Hepatic MonocytesHepatology, 2010
- Protective Roles of the Fractalkine/CX3CL1-CX3CR1 Interactions in Alkali-Induced Corneal Neovascularization through Enhanced Antiangiogenic Factor ExpressionThe Journal of Immunology, 2008
- CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degenerationJournal of Clinical Investigation, 2007
- Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and AdhesionCell, 1997